New pill may keep yeast infections away for good
NCT ID NCT03562156
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new oral medication, oteseconazole, to see if it can prevent recurrent yeast infections in women who have had at least three infections in the past year. Participants first received standard treatment for their current infection, then took either oteseconazole or a placebo for 12 weeks, followed by 36 weeks of monitoring. The goal was to see if the drug could reduce the number of future infections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT VULVOVAGINAL CANDIDIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
31102
Houston, Texas, 77054, United States
-
31103
Las Vegas, Nevada, 89128, United States
-
31105
Metairie, Louisiana, 70006, United States
-
31106
Wellington, Florida, 33414, United States
-
31107
Metarie, Louisiana, 70001, United States
-
31108
San Diego, California, 92111, United States
-
31111
Norcross, Georgia, 30095, United States
-
31113
Richmond, Virginia, 23225, United States
-
31114
Lawrenceville, New Jersey, 08648, United States
-
31116
Morehead City, North Carolina, 28557, United States
-
31117
Draper, Utah, 84020, United States
-
31118
Las Vegas, Nevada, 89123, United States
-
31120
Bristol, Tennessee, 37620, United States
-
31123
Birmingham, Alabama, 35233, United States
-
31125
Franklin, Ohio, 45005, United States
-
31127
West Seneca, New York, 14224, United States
-
31132
Greensboro, North Carolina, 27408, United States
-
31134
Philadelphia, Pennsylvania, 19102, United States
-
31139
Lauderdale Lakes, Florida, 33319, United States
-
31142
Port Jefferson, New York, 11777, United States
-
31143
Sarasota, Florida, 34239, United States
-
31144
Raleigh, North Carolina, 27607, United States
-
31145
Winston-Salem, North Carolina, 27103, United States
-
31146
Covington, Louisiana, 70433, United States
-
31147
Fall River, Massachusetts, 02720, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.